British American Tobacco/£BATS

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About British American Tobacco

The second-largest tobacco company by volume, British American Tobacco sold 505 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.

Ticker

£BATS

Primary listing

LSE

Employees

48,989

BATS Metrics

BasicAdvanced
£89B
29.75
£1.38
0.15
£2.38
5.87%

What the Analysts think about BATS

Analyst ratings (Buy, Hold, Sell) for British American Tobacco stock.

Bulls say / Bears say

BAT reported first-half 2025 adjusted diluted EPS of 162p, beating the analyst consensus of 154.8p, thanks to a 3.7% constant-currency increase in U.S. revenues and 3.9% growth in new category products. (Reuters)
Smokeless and next-generation products now make up over 18% of BAT’s total H1 2025 revenue, highlighting successful diversification beyond traditional cigarettes. (Reuters)
BAT raised its annual sales growth target to the upper end of 1%–2% and boosted its 2025 share buyback programme to £1.1 billion after selling its $1.5 billion ITC stake, increasing returns to shareholders. (Reuters)
BAT faces ongoing financial strain from a £6.2 billion Canadian class-action lawsuit, impacting its earnings outlook and capital allocation. (Reuters)
Tax increases in Bangladesh and Australia are set to reduce BAT’s traditional tobacco sales and limit revenue growth through 2025. (Reuters)
Illicit flavored disposable vapes in the U.S. and Canada are holding back BAT’s New Categories segment, restricting revenue growth to low single digits in H1 2025. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.

BATS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

BATS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £BATS

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Oct2
British American Tobacco
DividendEx-dividend
Nov7
British American Tobacco
DividendPayment
£0.6006Per share
Dec26
British American Tobacco
DividendEx-dividend
FAQs
Buy British American Tobacco stock | £BATS Share Price | Lightyear